Where U.S. Medicines Are Made and How Trump’s Tariffs Could Affect Them

The article discusses the potential impact of President Trump's proposed pharmaceutical tariffs on the production of common drugs in the United States. It highlights that many of the most widely used medications in the US are actually manufactured abroad, particularly in India and China. The article notes that a significant portion of the active pharmaceutical ingredients (APIs) used in US-sold drugs are imported from these countries. It suggests that the planned tariffs could lead to price hikes and supply chain disruptions for these essential medications. The article also mentions that the reliance on foreign drug production has been a long-standing issue, with concerns raised over the vulnerability of the US healthcare system to potential disruptions. The proposed tariffs are seen as a further complication to an already complex situation regarding the sourcing and affordability of prescription drugs in the country. Overall, the article highlights the widespread implications the tariffs could have on the availability and cost of common medications for American consumers.